Hannah Scott
Research Assistant
Research in lipidomics, ubiquitin biology and cancer immunology
I work at the Nuffield Department of Clinical Medicine (NDM) in the Mass Spectrometry and Life Sciences group (Kessler lab) within the Target Discovery Institute (TDI), the Centre for Medicines Discovery (CMD) and the Translational Ubiquitomics-Cancer Immunology group (Pinto-Fernandez lab) within the Chinese Academy of Medical Sciences Oxford Institute (CAMS-COI).
My research focusses on lipidomics, ubiquitin biology and cancer immunology. My research projects are based on:
1. Deubiquitylating enzymes (DUBs) of which ubiquitin specific protease 18 (USP18) and USP19 are of particular interest, especially their potential roles in lipid metabolism, inflammation, cancer immunology, muscle diseases, women's health, obesity and ageing.
2. Providing lipidomics and metabolomics analyses to collaborative partners as part of the Metabolomics Small Research Facility.
https://www.tdi.ox.ac.uk/research/research/tdi-mass-spectrometry-laboratory/mass-spectrometry/techniques-and-expertise/metabolomics-lipidomics
https://www.camsoxford.ox.ac.uk/research/groups/APF-group
My publications
Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Leukaemia.
E. Josue Ruiz, Adan Pinto-Fernandez, Andrew P. Turnbull, Linxiang Lan , Thomas M. Charlton, Hannah Claire Scott, Andreas Damianou, George Vere, Eva M. Riising, Clive Da Costa, Wojciech W. Krajewski, David Guerin, Jeffrey Kearns, Stephanos Ioannidis, Marie Katz, Crystal McKinnon, Jonathan C. O'Connell, Natalia Moncaut, Ian Rosewell, Emma Nye, Neil Jones, Claire Heride, Malte Gersch, Min Wu, Christopher J. Dinsmore, Tim R. Hammonds, Sunkyu Kim, David Komander, Sylvie Urbé, Michael J. Clague, Benedikt M. Kessler and Axel Behrens.
eLife 2021;10:e71596
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.